In-Vitro Activity of Polymyxin B, Rifampicin, Tigecycline Alone and in Combination against Carbapenem-Resistant Acinetobacter baumannii in Singapore

OBJECTIVE: Carbapenem-resistant Acinetobacter baumannii (CR-AB) is an emerging cause of nosocomial infections worldwide. Combination therapy may be the only viable option until new antibiotics become available. The objective of this study is to identify potential antimicrobial combinations against C...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Tze-Peng, Tan, Thean-Yen, Lee, Winnie, Sasikala, S., Tan, Thuan-Tong, Hsu, Li-Yang, Kwa, Andrea L.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3080872/
https://www.ncbi.nlm.nih.gov/pubmed/21533030
http://dx.doi.org/10.1371/journal.pone.0018485

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3080872/
https://www.ncbi.nlm.nih.gov/pubmed/21533030
http://dx.doi.org/10.1371/journal.pone.0018485

Ejemplares similares